PL3934671T3 - Mieszanina szczepów bakterii probiotycznych do stosowania w leczeniu astmy alergicznej i z nawracającym świszczącym oddechem, korzystnie u osobników pediatrycznych - Google Patents

Mieszanina szczepów bakterii probiotycznych do stosowania w leczeniu astmy alergicznej i z nawracającym świszczącym oddechem, korzystnie u osobników pediatrycznych

Info

Publication number
PL3934671T3
PL3934671T3 PL20716185.2T PL20716185T PL3934671T3 PL 3934671 T3 PL3934671 T3 PL 3934671T3 PL 20716185 T PL20716185 T PL 20716185T PL 3934671 T3 PL3934671 T3 PL 3934671T3
Authority
PL
Poland
Prior art keywords
mixture
treatment
probiotic bacteria
allergic asthma
bacteria strains
Prior art date
Application number
PL20716185.2T
Other languages
English (en)
Inventor
Vera Mogna
Marco Pane
Angela AMORUSO
Original Assignee
Probiotical S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical S.P.A. filed Critical Probiotical S.P.A.
Publication of PL3934671T3 publication Critical patent/PL3934671T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL20716185.2T 2019-03-07 2020-03-06 Mieszanina szczepów bakterii probiotycznych do stosowania w leczeniu astmy alergicznej i z nawracającym świszczącym oddechem, korzystnie u osobników pediatrycznych PL3934671T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT201900003351 2019-03-07
PCT/IB2020/051961 WO2020178794A1 (en) 2019-03-07 2020-03-06 Mixture of probiotic bacteria strains for use in the treatment of allergic asthma and with recurrent wheezing, preferably in paediatric subjects

Publications (1)

Publication Number Publication Date
PL3934671T3 true PL3934671T3 (pl) 2026-04-20

Family

ID=66690851

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20716185.2T PL3934671T3 (pl) 2019-03-07 2020-03-06 Mieszanina szczepów bakterii probiotycznych do stosowania w leczeniu astmy alergicznej i z nawracającym świszczącym oddechem, korzystnie u osobników pediatrycznych

Country Status (6)

Country Link
US (1) US12329791B2 (pl)
EP (2) EP3934671B1 (pl)
CN (1) CN113573721A (pl)
ES (1) ES3053838T3 (pl)
PL (1) PL3934671T3 (pl)
WO (1) WO2020178794A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1397566B1 (it) * 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
IT1398553B1 (it) 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011149335A1 (en) 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
KR20180118273A (ko) 2017-04-21 2018-10-31 박민경 유익균을 유효성분으로 하는 경비투여용 비염개선제 조성물
IT202100015398A1 (it) 2021-06-11 2022-12-11 Probiotical Spa Ceppi di batteri probiotici per uso in un metodo di trattamento preventivo o in un metodo di trattamento coadiuvante per le infezioni respiratorie virali

Also Published As

Publication number Publication date
CN113573721A (zh) 2021-10-29
EP3934671C0 (en) 2025-08-20
EP3934671B1 (en) 2025-08-20
WO2020178794A1 (en) 2020-09-10
US20220175855A1 (en) 2022-06-09
KR20210137056A (ko) 2021-11-17
EP4368252A3 (en) 2024-05-22
EP4368252A2 (en) 2024-05-15
EP3934671A1 (en) 2022-01-12
US12329791B2 (en) 2025-06-17
ES3053838T3 (en) 2026-01-27

Similar Documents

Publication Publication Date Title
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
WO2016086209A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
LT3849534T (lt) Dasatinibo ir adagrasibo derinys, skirtas panaudoti nesmulkialąstelinio plaučių vėžio gydymui
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
IL291445A (en) Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
IL263425A (en) Antagonistic t-linked antibodies to human tgfb2, tgfb1 and tgfb3 and their use for the treatment of pulmonary fibrosis
PL4014976T3 (pl) Aprocitentan do stosowania w leczeniu nadciśnienia tętniczego i chorób z nim związanych w połączeniu z walsartanem
IL262177B (en) Pyrimidinyl Carboxamide, 5-a] compounds and their use for the treatment of medical disorders
EP3452480A4 (en) SUBSTITUTED PYRROLO [1,2-] TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
PT3615035T (pt) Utilização de 20-hidroxiecdisona e os seus derivados no tratamento de miopatias
EP3969125A4 (en) USE OF ANTI-FCRN ANTIBODIES IN THE TREATMENT OF PEMPHIGHUS AND PEMPHIGOID DISEASES
IL264232A (en) Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
EP3648762A4 (en) USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED DISEASES
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
SG10201907549UA (en) A bifidobacterium lactis gkk2, a composition comprising thereof and its use for improving allergic asthma
EP4488288A3 (en) Means and methods for aav gene therapy in humans
SG10201907542SA (en) Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same
EP3620513A4 (en) COMPOSITION CONSISTING OF STRAINS CJLP475 OF LACTOBACILLUS PLANTARUM AND CJLP243 OF LACTOBACILLUS PLANTARUM, AND ASSOCIATED USE
PT3741218T (pt) Estirpe de lactobacillus salivarus e seu uso na prevenção e tratamento de diarreia pós-desmame em leitões
EP3761979A4 (en) USE OF GABOXADOL TO TREAT SUBSTANCE ABUSE
IL280859A (en) Use of gboxdol for the treatment of gastrointestinal disorders and asthma
PT3937949T (pt) Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória
EP4067504A4 (en) USE OF SYNAPTOTAGMINE-7 IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER
EP3934671C0 (en) A mixture of probiotic bacterial strains intended for use in the treatment of allergic asthma and recurrent wheezing, preferably in pediatric patients.
HK40053115A (en) Use of gaboxadol in the treatment of gastrointestinal tract disorders and asthma